AKT1 and esophageal cancer: Kong et al. (2021) also reported that NOLC1 over-expression is considered to be an independent adverse factor affecting the overall survival of esophageal cancer patients and can participate in the invasion and protein expression of esophageal cancer through the PI3K/AKT pathway.